The Investigator Databank is a global collaboration between pharmaceutical companies to share investigator information that each company has on file with one another. Investigator Databank aims to reduce administrative burden for investigators and to increase visibility of qualified investigators to research sponsors.
Helps the busy sites like us to use a centralized data bank to timely update the site information. I wish other pharmaceutical companies will also support this effort.
AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Lilly, Merck Sharp & Dohme Corp., NJ, USA, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi and UCB.
Creating a profile is easy and quick, and it allows sponsors to immediately begin viewing your details. Once registered, all you need to do is “opt-in” to start sharing with the Investigator Databank and be taken to your profile where you can view, edit, and comment on information from industry member’s clinical trial management systems.Create a Profile
There is no charge to investigators or their institutions to opt-in to the Investigator Databank and to create a profile. Industry member companies share the financial support for development and access to the Databank.
Member pharma companies benefit from the following: